Korro Bio, Inc.
KRRO · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $6.39M | $2.27M | +181% |
| Operating income | −$122M | −$91.9M | −32.6% |
| Net income | −$117M | −$83.6M | −40.3% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 5, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $0K | $1.10M | −100% |
| Operating income | −$18.5M | −$19.2M | +3.6% |
| Net income | −$17.5M | −$18.1M | +3.3% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was Korro Bio's revenue in FY2025?
- $6.39M in FY2025 (Fiscal year ended Dec 31, 2025), +181% vs $2.27M a year earlier, per its 10-K filed Mar 2026.
- Was Korro Bio profitable in FY2025?
- No: net income was −$117M and operating income −$122M in FY2025.
- What was Korro Bio's revenue in Q3 2026?
- $0K (−100% vs a year earlier), per its Form 10-Q filed Nov 5, 2026.